MediPharm Labs Closes Previously Announced Bought Deal Equity Financing

"MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the closing of its previously announced “bought deal” offering of units of the Company (the “Units”) for total gross proceeds of $33,350,000. .."

030521 MediPharm Labs Closes Previously
Download • 81KB

Cannabis and Hemp Insider

A Program of FC Global Strategies LLC

383 Corona Street

Suite 589

Denver CO 80218 USA 

Tel.+1 303 478 4887